Chimeric EWS-FLI1 transcript in a Ewing cell line with a complex t(11;22;14) translocation

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Peripheral neuroectodermal tumors (PNETs) encompass neuroepithelioma and Ewing's tumor.
• A t(11;22) translocation involving EWS and Fli-1 genes is characteristic of most PNETs.
• Differential diagnosis of small round cell tumors in children can be challenging.

Purpose of the Study:

• To investigate the molecular basis of a Ewing's tumor case with an atypical translocation.
• To determine if the atypical translocation results in the characteristic EWS-Fli-1 fusion transcript.
• To assess the implications for molecular diagnostic assay development for PNETs.

Main Methods:

• Analysis of an Ewing's tumor cell line with a t(11;22;14) translocation.
• Reverse transcription-polymerase chain reaction (RT-PCR) to detect EWS-Fli-1 fusion transcripts.
• Direct sequencing of the amplified product.

Main Results:

• An EWS-Fli-1 fusion transcript was successfully detected in the Ewing's tumor cell line.
• The molecular rearrangement in this atypical case generated a fusion transcript identical to those in typical t(11;22) translocations.
• This finding validates the presence of the EWS-Fli-1 fusion in PNETs regardless of translocation complexity.

Conclusions:

• The EWS-Fli-1 fusion transcript is consistently produced in Ewing's sarcoma, even with complex chromosomal translocations.
• Molecular detection of the EWS-Fli-1 fusion is a reliable diagnostic marker for PNETs.
• This supports the development of molecular diagnostic tools for challenging small round cell tumor diagnoses.